LGW16-03 for Nerve Identification

This trial tests a new drug, LGW16-03, to determine its safety and effectiveness in helping doctors visualize major nerves during open-field orthopedic surgery. The goal is to identify a safe dose that provides a clear image of the nerves to assist surgeons. The trial seeks individuals scheduled for this type of surgery who have normal nerve function. Participants will receive a one-time infusion of the drug before surgery and will attend follow-up visits. As a Phase 1 trial, this research aims to understand how the treatment works in people, offering participants the opportunity to be among the first to receive this new drug.

The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the study team or your doctor to ensure safety and compliance with the trial requirements.

Research has shown that LGW16-03, a new glowing dye for marking nerves, is in the early stages of testing for safety in humans. Previously, lab studies without human subjects found that the dye could successfully highlight nerve tissues, aiding visibility during surgery.

In this early human trial stage, the primary goal is to assess the safety of LGW16-03 and its potential for use without serious side effects. Participants receive a one-time dose before surgery, and doctors closely monitor their health and take blood samples to track how the dye moves through the body.

Researchers are excited about LGW16-03 for nerve identification because it offers a novel approach to a common surgical challenge: accurately identifying nerves. Unlike traditional methods that rely on visual cues and anatomical knowledge, LGW16-03 is administered through a single IV infusion, potentially providing a more precise and less invasive way to highlight nerves during surgery. This could reduce the risk of nerve damage and improve surgical outcomes, making it a promising advancement over existing techniques.

Research has shown that LGW16-03, a special dye, can help highlight nerves during surgery. Early studies found that LGW16-03 makes nerve tissues glow, enhancing visibility. This improved visibility helps surgeons avoid nerve damage during operations. Tests with human tissues demonstrated similar success in identifying nerves, suggesting that LGW16-03 could be very helpful in real surgeries. Although data from human trials remains limited, these early results support the idea that LGW16-03 can make surgeries safer by clearly identifying nerves.¹⁴⁶⁷⁸